Electromed Change To Inventory vs Begin Period Cash Flow Analysis
ELMD Stock | USD 29.80 0.22 0.74% |
Electromed financial indicator trend analysis is much more than just examining Electromed latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Electromed is a good investment. Please check the relationship between Electromed Change To Inventory and its Begin Period Cash Flow accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.
Change To Inventory vs Begin Period Cash Flow
Change To Inventory vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Electromed Change To Inventory account and Begin Period Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Electromed's Change To Inventory and Begin Period Cash Flow is -0.1. Overlapping area represents the amount of variation of Change To Inventory that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Electromed, assuming nothing else is changed. The correlation between historical values of Electromed's Change To Inventory and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Inventory of Electromed are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Change To Inventory i.e., Electromed's Change To Inventory and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.1 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most indicators from Electromed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Electromed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.At present, Electromed's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 14.88, whereas Selling General Administrative is forecasted to decline to about 18.5 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 25K | 78K | 89.7K | 85.2K | Depreciation And Amortization | 628K | 613K | 841K | 684.7K |
Electromed fundamental ratios Correlations
Click cells to compare fundamentals
Electromed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Electromed fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 33.2M | 37.1M | 41.4M | 45.8M | 52.2M | 28.3M | |
Short Long Term Debt Total | 45.1K | 81.2K | 87K | 41K | 161K | 82.7K | |
Other Current Liab | 2.4M | 3.7M | 5.8M | 6.3M | 6.4M | 6.7M | |
Total Current Liabilities | 3.0M | 4.6M | 7.2M | 8.1M | 7.7M | 4.5M | |
Total Stockholder Equity | 30.2M | 32.4M | 34.2M | 37.7M | 44.5M | 22.6M | |
Property Plant And Equipment Net | 3.9M | 3.7M | 4.7M | 5.7M | 5.3M | 4.0M | |
Net Debt | (10.4M) | (11.8M) | (8.1M) | (7.2M) | (16.1M) | (15.3M) | |
Retained Earnings | 13.7M | 14.9M | 15.8M | 18.8M | 23.7M | 24.9M | |
Accounts Payable | 555.5K | 685K | 1.3M | 1.4M | 1.0M | 814.3K | |
Cash | 10.5M | 11.9M | 8.2M | 7.4M | 16.1M | 16.9M | |
Non Current Assets Total | 5.2M | 5.4M | 6.8M | 8.0M | 8.1M | 5.6M | |
Non Currrent Assets Other | 80.2K | 88K | 120M | 161K | 87K | 82.7K | |
Other Assets | 755K | 1.1M | 1.5M | 1.6M | 1.0 | 0.95 | |
Cash And Short Term Investments | 10.5M | 11.9M | 8.2M | 7.4M | 16.1M | 16.9M | |
Net Receivables | 14.1M | 17.4M | 21.3M | 24.6M | 24.1M | 13.3M | |
Common Stock Total Equity | 84.1K | 85.7K | 85K | 86K | 98.9K | 86.6K | |
Common Stock Shares Outstanding | 8.8M | 8.9M | 8.8M | 8.7M | 8.9M | 8.9M | |
Liabilities And Stockholders Equity | 33.2M | 37.1M | 41.4M | 45.8M | 52.2M | 28.3M | |
Non Current Liabilities Total | 8.9K | 54K | 41K | 86K | 12K | 11.4K | |
Inventory | 3.1M | 2.1M | 3.2M | 4.2M | 3.7M | 2.6M | |
Other Current Assets | 353.3K | 276K | 1.9M | 1.6M | 329.0K | 312.6K | |
Other Stockholder Equity | 16.5M | 17.4M | 18.3M | 18.8M | 20.8M | 16.5M | |
Total Liab | 3.0M | 4.7M | 7.2M | 8.1M | 7.7M | 5.6M | |
Property Plant And Equipment Gross | 3.8M | 3.6M | 4.7M | 5.7M | 10.4M | 10.9M | |
Total Current Assets | 28.0M | 31.7M | 34.5M | 37.8M | 44.2M | 22.7M | |
Short Term Debt | 30.3K | 72.3K | 33K | 80K | 72K | 68.4K | |
Intangible Assets | 598.4K | 663K | 599K | 605K | 657K | 624.2K | |
Common Stock | 84.1K | 85.7K | 85K | 86K | 87K | 87.1K | |
Property Plant Equipment | 3.9M | 3.6M | 4.6M | 5.7M | 6.5M | 3.9M | |
Current Deferred Revenue | (72.3K) | (33K) | 1.5B | (80K) | 277K | 263.2K | |
Net Tangible Assets | 29.7M | 31.8M | 33.6M | 37.1M | 42.6M | 24.2M | |
Retained Earnings Total Equity | 13.7M | 14.9M | 15.8M | 18.8M | 21.6M | 22.7M | |
Capital Surpluse | 16.5M | 17.4M | 18.3M | 18.8M | 21.6M | 16.7M | |
Net Invested Capital | 30.2M | 32.4M | 34.2M | 37.7M | 44.5M | 34.1M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.809 | Earnings Share 0.72 | Revenue Per Share 6.39 | Quarterly Revenue Growth 0.09 | Return On Assets 0.0839 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.